← Open Payments lookup

KATELYNE HALE: Open Payments

NPI 1578084091 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,072 in 80 payments from 16 companies in 2025. Trend: 2023 $2,042 · 2024 $1,240 · 2025 $2,072

Food & beverage: $2,072
CompanyPaymentsAmount
ABBVIE INC.22$444
Janssen Biotech, Inc.14$374
Takeda Pharmaceuticals U.S.A., Inc.9$220
Ardelyx, Inc.5$174
Ipsen Biopharmaceuticals, Inc2$146
QOL Medical, LLC6$144
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$110
Regeneron Healthcare Solutions, Inc.3$83
Madrigal Pharmaceuticals1$80
Celltrion USA Inc.3$70

Products named: TREMFYA, ENTYVIO, IBSRELA, RINVOQ, IQIRVO, SKYRIZI, Sucraid, XIFAXAN.

Industry payments across VA — which companies pay providers there.